Pfizer settles Biohaven kickback case with DOJ for $60M

Pfizer (NYSE:PFE) has agreed to pay nearly $60M to resolve allegations that its Biohaven unit paid kickbacks to physicians to induce prescriptions for its migraine drug Nurtec ODT.

The U.S. Department of Justice alleged Biohaven knowingly caused the submission of false